MetaCap

Acumen Pharmaceuticals (ABOS) News

NASDAQ: ABOSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.1865-0.0068 (-3.52%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ABOS news summary

We found 13 recent headlines mentioning Acumen Pharmaceuticals (ABOS): 0 in the past week and 10 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, ABOS is down 3.52% at $0.1865. The most recent story, "Acumen Pharmaceuticals, Inc. Announces 90% Workforce Reduction and Terminates Loan Agreement with $23.3 million Payoff", was published by Nasdaq on Nov 6, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Acumen Pharmaceuticals headlines

Stocks mentioned alongside ABOS

Compare ABOS